Efficacy of Intermittent or Continuous Very Low-Energy Diets in Overweight and Obese Individuals with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analyses
Table 3
The GRADE evidence of VLEDs compared to LEDs for overweight and obese people with type 2 diabetes mellitus.
Quality assessment
No. of patients
Effect
Quality
Importance
No. of studies
Design
Risk of bias
Inconsistency
Indirectness
Imprecision
Other considerations
VLED
LED
Relative (95% CI)
Absolute
Weight (better indicated by lower values)
8
Randomized trials
Serious1
No serious inconsistency
Serious2
No serious imprecision
None
246
241
—
MD -1.86 lower (-3.34 to -0.37 lower)
Low
9
Weight: end of the intervention (better indicated by lower values)
5
Randomized trials
Serious1
No serious inconsistency
Serious2
No serious imprecision
None
151
146
—
MD -2.77 lower (-4.81 to -0.72 lower)
Low
9
Weight: (better indicated by lower values)
3
Randomized trials
Serious1
No serious inconsistency
Serious2
Serious3
None
95
95
—
MD -0.84 lower (-3.01 lower to 1.32 higher)
Very low
9
Glucose (better indicated by lower values)
6
Randomized trials
Serious1
No serious inconsistency
Serious2
No serious imprecision
None
187
180
—
MD -1.26 lower (-1.97 to -0.55 lower)
Low
8
Glucose: end of the intervention (better indicated by lower values)
3
Randomized trials
Serious1
No serious inconsistency
Serious2
No serious imprecision
None
75
76
—
MD -1.18 lower (-2.05 to -0.3 lower)
Low
8
Glucose: (better indicated by lower values)
3
Randomized trials
Serious1
No serious inconsistency
Serious2
Serious4
None
112
104
—
MD -1.43 lower (-2.65 to -0.2 lower)
Very low
8
TG (better indicated by lower values)
6
Randomized trials
Serious1
No serious inconsistency
Serious2
No serious imprecision
None
185
179
—
MD 0.31 lower (-0.5 to -0.13 lower)
Low
7
TG: end of the intervention (better indicated by lower values)
3
Randomized trials
Serious1
No serious inconsistency
Serious2
No serious imprecision
None
75
76
—
MD -0.35 lower (-0.58 to -0.12 lower)
Low
7
TG: (better indicated by lower values)
3
Randomized trials
Serious1
No serious inconsistency
Serious2
Serious4
None
110
103
—
MD -0.25 lower (-0.55 lower to 0.06 higher)
Very low
7
Dropout
6
Randomized trials
Serious1
No serious inconsistency
Serious2
No serious imprecision
None
57/253 (22.5%)
69/253 (27.3%)
OR 0.74 (0.49 to 1.13)
56 fewer per 1000 (from 118 fewer to 25 more)
Low
6
21.4%
46 fewer per 1000 (from 96 fewer to 21 more)
CI: confidence interval; OR: odds ratio. GRADE Working Group grades of evidence: high quality: further research is very unlikely to change our confidence in the estimate of effect; moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate; low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate; very low quality: we are very uncertain about the estimate. 1There are studies that do not account for specific stochastic methods, so they are reduced by one level. 2Interventions include continuous VLEDs and intermittent VLEDs, which differ to some extent, so they are reduced by one level. 3No explanation was provided. 4The ratio of 95% CI to the effect is more than 50%. 95% CI is wider and its accuracy is poor, so it decreases one level.